Continent 2 Continent 4 Cancer (C2C4C) 2025 - Asia Pacific

The 2025 Continent 2 Continent 4 Cancer (C2C4C) ride in Japan organised by Bristol Myers Squibb will feature 60 of the company's employees from seven nations cycling from 7-21 October in support of the Union for International Cancer Control (UICC) and selected members in Asia Pacific to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.

The inaugural C2C4C ride was held twelve years ago in the United States as Coast 2 Coast 4 Cancer. Riders in Europe joined the effort in 2016 for the Country 2 Country 4 Cancer, Japan in 2021 and Latin America in 2022 as the Continent 2 Continent 4 Cancer.

For the fifth year, the 2025 edition of the Continent 2 Continent 4 Cancer (C2C4C) ride will feature 60 Bristol Myers Squibb employees riding nearly 1,800 kilometers from 7-21 October.

The 15-day event involves five teams each cycling a three-day segment. Since 2021, more than USD 550,000 has been donated to charitable organizations in Asia Pacific via the C2C4C ride.

In this 2025 edition, five teams will feature riders participating from seven countries including Australia, China, India, Japan, Korea, Singapore, and the United States. The mission of C2C4C is to raise awareness for cancer research and Asia Pacific cancer organisations who are members of the UICC.

Who are the riders

The participants are novice riders who have committed themselves to five months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting Asia Pacific cancer organisations, who are members of the UICC.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

For more information about Bristol Myers Squibb, visit us at BMS.com or follow them on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

Why raise funds for cancer organisations

Cancer is among the leading causes of death worldwide. In 2022, there were 20 million new cases and 9.7 million cancer-related deaths worldwide, and the number of cases are expected to rise further in the coming decade.

This is why Bristol Myers Squibb chooses to support the UICC and its members in their mission to reduce the global cancer burden, promote greater equity, and ensure that cancer is a priority on the world health and development agenda.

Encourage your colleagues, family and friends to donate as cancer affects us all. Each team rides and raises funds for members of the Union for International Control.

Quotes

“The C2C4C ride unites us, fostering teamwork in honor of our friends, family, and the countless cancer patients we strive to support daily through our work. I am deeply moved by the significance of this initiative to all of us. I had the honour to ride the C2C4C last year in Latin America and live this unforgettable experience. This year, I will be supporting my colleagues from the European teams and contribute to raising funds for UICC's members to ensure patients receive the diagnosis, treatment, and care necessary to fight cancer.”

Emma Charles

Emma Charles, Senior Vice President, Europe Region, Bristol Myers Squibb

“As the C2C4C initiative enters a new chapter with its expansion into Asia, we are reminded of the global spirit that drives these events. The energy and dedication of the participants embody the kind of collaboration and shared purpose that are essential to advancing people-centred cancer care. On behalf of UICC’s members, I thank Bristol Myers Squibb for their unwavering commitment and continued partnership in this shared mission.”

Cary Adams

CEO, Union for International Cancer Control (UICC)